Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Novel Eye-Tracking Methods to Evaluate the Usability of Electronic Health Records.

Jayachander D, Coleman C, Rand V, Newlin T, Khairat S.

Stud Health Technol Inform. 2019 Jul 4;262:244-247. doi: 10.3233/SHTI190064.

PMID:
31349313
2.

Understanding the Impact of Clinical Training on EHR Use Optimization.

Khairat S, Jayachander D, Coleman C, Newlin T, Rand V.

Stud Health Technol Inform. 2019 Jul 4;262:240-243. doi: 10.3233/SHTI190063.

PMID:
31349312
3.

Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif.

Zhou P, Blain AE, Newman AM, Zaka M, Chagaluka G, Adlar FR, Offor UT, Broadbent C, Chaytor L, Whitehead A, Hall A, O'Connor H, Van Noorden S, Lampert I, Bailey S, Molyneux E, Bacon CM, Bomken S, Rand V.

Blood Adv. 2019 Jul 23;3(14):2118-2127. doi: 10.1182/bloodadvances.2018029546.

4.

A mixed-methods evaluation framework for electronic health records usability studies.

Khairat S, Coleman C, Newlin T, Rand V, Ottmar P, Bice T, Carson SS.

J Biomed Inform. 2019 Jun;94:103175. doi: 10.1016/j.jbi.2019.103175. Epub 2019 Apr 11.

PMID:
30981897
5.

Towards Understanding the Impact of EHR-Related Information Overload on Provider Cognition.

Rand V, Coleman C, Park R, Karar A, Khairat S.

Stud Health Technol Inform. 2018;251:277-280.

PMID:
29968657
6.

Classifying Provider-EHR Screen Interactions During ICU Pre-Rounds.

Khairat S, Coleman C, Rand V, James E, Bice T.

Stud Health Technol Inform. 2018;251:265-268.

PMID:
29968654
7.

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.

Noble RA, Bell N, Blair H, Sikka A, Thomas H, Phillips N, Nakjang S, Miwa S, Crossland R, Rand V, Televantou D, Long A, Keun HC, Bacon CM, Bomken S, Critchlow SE, Wedge SR.

Haematologica. 2017 Jul;102(7):1247-1257. doi: 10.3324/haematol.2016.163030. Epub 2017 Apr 6.

8.

IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.

Mazya MV, Lees KR, Collas D, Rand VM, Mikulik R, Toni D, Wahlgren N, Ahmed N.

Neurology. 2015 Dec 15;85(24):2098-106. doi: 10.1212/WNL.0000000000002199. Epub 2015 Nov 6.

9.

Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.

Gabriel AS, Lafta FM, Schwalbe EC, Nakjang S, Cockell SJ, Iliasova A, Enshaei A, Schwab C, Rand V, Clifford SC, Kinsey SE, Mitchell CD, Vora A, Harrison CJ, Moorman AV, Strathdee G.

Epigenetics. 2015;10(8):717-26. doi: 10.1080/15592294.2015.1061174.

10.

c-MYC is a radiosensitive locus in human breast cells.

Wade MA, Sunter NJ, Fordham SE, Long A, Masic D, Russell LJ, Harrison CJ, Rand V, Elstob C, Bown N, Rowe D, Lowe C, Cuthbert G, Bennett S, Crosier S, Bacon CM, Onel K, Scott K, Scott D, Travis LB, May FE, Allan JM.

Oncogene. 2015 Sep 17;34(38):4985-94. doi: 10.1038/onc.2014.427. Epub 2014 Dec 22.

11.

Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.

Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, Rodig SJ.

J Mol Diagn. 2015 Jan;17(1):19-30. doi: 10.1016/j.jmoldx.2014.08.006. Epub 2014 Nov 7.

12.

Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia.

Li Y, Schwab C, Ryan S, Papaemmanuil E, Robinson HM, Jacobs P, Moorman AV, Dyer S, Borrow J, Griffiths M, Heerema NA, Carroll AJ, Talley P, Bown N, Telford N, Ross FM, Gaunt L, McNally RJQ, Young BD, Sinclair P, Rand V, Teixeira MR, Joseph O, Robinson B, Maddison M, Dastugue N, Vandenberghe P, Stephens PJ, Cheng J, Van Loo P, Stratton MR, Campbell PJ, Harrison CJ.

Nature. 2014 Apr 3;508(7494):98-102. doi: 10.1038/nature13115. Epub 2014 Mar 23.

13.

BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.

Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Ng C, Titz B, Hurtz C, Sadiyah MF, Nowak D, Thoennissen GB, Rand V, Graeber TG, Koeffler HP, Carroll WL, Willman CL, Hall AG, Igarashi K, Melnick A, Müschen M.

Nat Med. 2013 Aug;19(8):1014-22. doi: 10.1038/nm.3247. Epub 2013 Jul 14.

14.

Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency.

Bacon CM, Wilkinson SJ, Spickett GP, Barge D, Lucraft HH, Jackson G, Rand V, Gennery AR.

J Allergy Clin Immunol. 2013 Apr;131(4):1237-9, 1239.e1. doi: 10.1016/j.jaci.2012.10.027. Epub 2012 Dec 8. No abstract available.

PMID:
23228243
15.

Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity.

Thathia SH, Ferguson S, Gautrey HE, van Otterdijk SD, Hili M, Rand V, Moorman AV, Meyer S, Brown R, Strathdee G.

Haematologica. 2012 Mar;97(3):371-8. doi: 10.3324/haematol.2011.049593. Epub 2011 Nov 4.

16.

Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Miller S, Rogers HA, Lyon P, Rand V, Adamowicz-Brice M, Clifford SC, Hayden JT, Dyer S, Pfister S, Korshunov A, Brundler MA, Lowe J, Coyle B, Grundy RG.

Neuro Oncol. 2011 Aug;13(8):866-79. doi: 10.1093/neuonc/nor070.

17.

Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.

Rand V, Parker H, Russell LJ, Schwab C, Ensor H, Irving J, Jones L, Masic D, Minto L, Morrison H, Ryan S, Robinson H, Sinclair P, Moorman AV, Strefford JC, Harrison CJ.

Blood. 2011 Jun 23;117(25):6848-55. doi: 10.1182/blood-2011-01-329961. Epub 2011 Apr 28.

18.

Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy.

Sinclair PB, Parker H, An Q, Rand V, Ensor H, Harrison CJ, Strefford JC.

Hum Mol Genet. 2011 Jul 1;20(13):2591-602. doi: 10.1093/hmg/ddr159. Epub 2011 Apr 12.

PMID:
21487021
19.

Cross-species genomics matches driver mutations and cell compartments to model ependymoma.

Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ.

Nature. 2010 Jul 29;466(7306):632-6. doi: 10.1038/nature09173. Epub 2010 Jul 18.

20.

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, Chapiro E, Gesk S, Griffiths M, Guttery DS, Haferlach C, Harder L, Heidenreich O, Irving J, Kearney L, Nguyen-Khac F, Machado L, Minto L, Majid A, Moorman AV, Morrison H, Rand V, Strefford JC, Schwab C, Tönnies H, Dyer MJ, Siebert R, Harrison CJ.

Blood. 2009 Sep 24;114(13):2688-98. doi: 10.1182/blood-2009-03-208397. Epub 2009 Jul 29.

21.

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma.

Rand V, Prebble E, Ridley L, Howard M, Wei W, Brundler MA, Fee BE, Riggins GJ, Coyle B, Grundy RG; Children's Cancer and Leukaemia Group Biological Studies Committee.

Br J Cancer. 2008 Oct 7;99(7):1136-43. doi: 10.1038/sj.bjc.6604651. Epub 2008 Sep 9.

22.
23.

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.

Ridley L, Rahman R, Brundler MA, Ellison D, Lowe J, Robson K, Prebble E, Luckett I, Gilbertson RJ, Parkes S, Rand V, Coyle B, Grundy RG; Children's Cancer and Leukaemia Group Biological Studies Committee.

Neuro Oncol. 2008 Oct;10(5):675-89. doi: 10.1215/15228517-2008-036. Epub 2008 Aug 13.

24.

PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.

Gallia GL, Rand V, Siu IM, Eberhart CG, James CD, Marie SK, Oba-Shinjo SM, Carlotti CG, Caballero OL, Simpson AJ, Brock MV, Massion PP, Carson BS Sr, Riggins GJ.

Mol Cancer Res. 2006 Oct;4(10):709-14.

25.

Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.

Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, Busam D, Li K, Edwards JB, Eberhart C, Murphy KM, Tsiamouri A, Beeson K, Simpson AJ, Venter JC, Riggins GJ, Strausberg RL.

Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14344-9. Epub 2005 Sep 26.

26.

Gene map of the extended human MHC.

Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S.

Nat Rev Genet. 2004 Dec;5(12):889-99. Review.

PMID:
15573121
27.

Alternative therapies for male and female sexual dysfunction.

Aung HH, Dey L, Rand V, Yuan CS.

Am J Chin Med. 2004;32(2):161-73. Review.

PMID:
15315255
28.

DNA sequence and analysis of human chromosome 9.

Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD, Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD, Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beasley H, Beasley O, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burford D, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Chen Y, Clarke G, Clark SY, Clee CM, Clegg S, Collier RE, Corby N, Crosier M, Cummings AT, Davies J, Dhami P, Dunn M, Dutta I, Dyer LW, Earthrowl ME, Faulkner L, Fleming CJ, Frankish A, Frankland JA, French L, Fricker DG, Garner P, Garnett J, Ghori J, Gilbert JG, Glison C, Grafham DV, Gribble S, Griffiths C, Griffiths-Jones S, Grocock R, Guy J, Hall RE, Hammond S, Harley JL, Harrison ES, Hart EA, Heath PD, Henderson CD, Hopkins BL, Howard PJ, Howden PJ, Huckle E, Johnson C, Johnson D, Joy AA, Kay M, Keenan S, Kershaw JK, Kimberley AM, King A, Knights A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd C, Lloyd DM, Lovell J, Martin S, Mashreghi-Mohammadi M, Matthews L, McLaren S, McLay KE, McMurray A, Milne S, Nickerson T, Nisbett J, Nordsiek G, Pearce AV, Peck AI, Porter KM, Pandian R, Pelan S, Phillimore B, Povey S, Ramsey Y, Rand V, Scharfe M, Sehra HK, Shownkeen R, Sims SK, Skuce CD, Smith M, Steward CA, Swarbreck D, Sycamore N, Tester J, Thorpe A, Tracey A, Tromans A, Thomas DW, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Williams SA, Wilming L, Wray PW, Young L, Ashurst JL, Coulson A, Blöcker H, Durbin R, Sulston JE, Hubbard T, Jackson MJ, Bentley DR, Beck S, Rogers J, Dunham I.

Nature. 2004 May 27;429(6990):369-74.

29.

The current availability of neurological in-patient services in post-communist central and eastern European countries.

Herzig R, Kalvach P, Petkova V, Vuković V, Tsakadze NL, Bereczki D, Tuta S, Martiníková M, Rot U, Xhaxho S, Sidorovich E, Rand VM, Zaborski J, Gavriliuc M, Reminyak IV.

Neuroepidemiology. 2003 Jul-Aug;22(4):255-64.

PMID:
12792147
30.

Estrogen receptor ligands affect mitochondrial activity in SH-SY5Y human neuroblastoma cells.

Simpson PB, Woollacott AJ, Moneer Z, Rand V, Seabrook GR.

Neuroreport. 2002 May 24;13(7):957-60.

PMID:
12004198
31.

Effect of evaluator and resident gender on the American Board of Internal Medicine evaluation scores.

Rand VE, Hudes ES, Browner WS, Wachter RM, Avins AL.

J Gen Intern Med. 1998 Oct;13(10):670-4.

Supplemental Content

Support Center